FDA Inspection 1036201 — North Texas Male Infertility Center, P.A.
The FDA completed an inspection of North Texas Male Infertility Center, P.A. on December 19, 2017 in Frisco, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 19, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Frisco, TX (United States)